Rootsaert Rodney Gerard 4
4 · VOLITIONRX LTD · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
VolitionRx (VNRX) Secretary Rodney Rootsaert Has Shares Withheld for Taxes
What Happened
Rodney Gerard Rootsaert, Secretary of VolitionRx Ltd. (VNRX), had 3,948 shares of common stock disposed on March 17, 2026 as a payment of tax liability (Form 4 code F). The shares were recorded at $0.19 each, totaling about $750. The transaction was to satisfy tax withholding upon settlement of 9,400 restricted stock units (RSUs).
According to the filing footnote, the 3,948 shares were retained by VolitionRx for cancellation to meet withholding obligations; no shares were sold by the reporting person or by the company.
Key Details
- Transaction date: 2026-03-17; filing date (Form 4): 2026-03-19 (filed within the normal 2‑business‑day window).
- Transaction type/code: Payment of tax liability / withholding (code F).
- Quantity and price: 3,948 shares at $0.19 per share; reported value ≈ $750.
- Reason: Withholding to satisfy taxes on settlement of 9,400 RSUs (footnote F1).
- Ownership note: Shares are held directly by Concord International, Inc.; Rootsaert is a controlling director and shares voting/dispositive control over those shares (footnote F2).
- Shares owned after transaction: Not specified in the provided summary.
Context
- This is a routine tax‑withholding (cashless) action tied to RSU settlement, not an open‑market sale, and therefore should not be read as an active sell signal. The filing appears timely and factual; it does not reveal the reporting person's intent beyond satisfying tax obligations.
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Rootsaert Rodney Gerard
Secretary
Transactions
- Tax Payment
Common Stock
[F1]2026-03-17$0.19/sh−3,948$750→ 273,993 total
Holdings
- 1,007,718(indirect: By Concord International, Inc.)
Common Stock
[F2]
Footnotes (2)
- [F1]Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,400 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
- [F2]The shares of common stock are held directly by Concord International, Inc. The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.
Signature
/s/ Rodney Gerard Rootsaert|2026-03-19